|
C8ORF41 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.0817000003286E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.492799998701E-08 |
| Normal-vs-Stage2 |
4.218000E-03 |
| Normal-vs-Stage3 |
4.993600E-01 |
| Normal-vs-Stage4 |
4.521600E-01 |
| Stage1-vs-Stage2 |
3.371400E-01 |
| Stage1-vs-Stage3 |
1.463640E-03 |
| Stage1-vs-Stage4 |
1.036560E-01 |
| Stage2-vs-Stage3 |
1.040950E-01 |
| Stage2-vs-Stage4 |
4.037000E-01 |
| Stage3-vs-Stage4 |
7.052400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.65179999975929E-07 |
| Normal-vs-AfricanAmerican |
1.769040E-04 |
| Normal-vs-Asian |
4.064600E-01 |
| Caucasian-vs-AfricanAmerican |
7.613800E-01 |
| Caucasian-vs-Asian |
9.071200E-01 |
| AfricanAmerican-vs-Asian |
9.556000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.16870000010927E-07 |
| Normal-vs-Female |
4.803900E-03 |
| Male-vs-Female |
1.925630E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.222900E-04 |
| Normal-vs-Extreme_Weight |
1.69418000000032E-05 |
| Normal-vs-Obese |
3.432600E-04 |
| Normal-vs-Extreme_Obese |
7.616300E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.752000E-01 |
| Normal_Weight-vs-Obese |
6.834600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.095800E-01 |
| Extreme_Weight-vs-Obese |
4.425800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.168600E-01 |
| Obese-vs-Extreme_Obese |
1.955160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.216600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.196900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.12339999525091E-08 |
| Normal-vs-Age(81-100Yrs) |
4.632500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.214400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.047980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.755630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.260900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.587400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.896000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.97620000030874E-07 |
| Normal-VS-Type2 PRCC |
8.0659000000094E-05 |
| Normal-VS-KIRP CIMP |
6.953800E-01 |
| Normal-VS-Unclassified PRCC |
2.553700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.697000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.082000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.760000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.380760E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.870600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.756200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.779710E-04 |
| Normal-vs-N1 |
1.136160E-01 |
| Normal-vs-N2 |
6.758800E-01 |
| N0-vs-N1 |
1.872170E-01 |
| N0-vs-N2 |
6.141700E-02 |
| N1-vs-N2 |
2.390000E-01 |
|
|
